Comparative Study of Antitumor Efficiency of Intraperitoneal and Intravenous Cytostatics in Experimental Rats with Disseminated Ovarian Cancer


Цитировать

Полный текст

Открытый доступ Открытый доступ
Доступ закрыт Доступ предоставлен
Доступ закрыт Только для подписчиков

Аннотация

Antitumor efficiencies of cytostatics dioxadet, cisplatin, mitomycin C, melphalan, and paclitaxel after a single intraperitoneal or intravenous injection in doses of 1.5, 4, 1.5, 2, and 5 mg/kg, respectively, were studied on the model of transplanted ovarian tumor in 124 rats. The antitumor effects were evaluated by the increase in median survival. Dioxadet, cisplatin, and melphalan injected intraperitoneally significantly prolonged the lifespan median – by 79, 88, and 114%, respectively, and were in fact ineffective, when injected intravenously. Intraperitoneal mitomycin C prolonged lifespan median by just 35%, intravenous – by 152%. Paclitaxel injected intraperitoneally and intravenously prolonged the lifespan median by 45 and 81%, respectively.

Об авторах

V. Bespalov

Research Laboratory of Cancer Chemoprophylaxis and Oncopharmacology, I. N. Petrov Research Institute of Oncology, Ministry of Health of the Russian Federation; International Research Centre “Biotechnologies of the Third Millennium”, ITMO University (St. Petersburg National Research University of Information Technologies, Mechanics and Optics

Email: iravasilyeva@hotmail.com
Россия, St. Petersburg; St. Petersburg

E. Vyshinskaya

Research Laboratory of Cancer Chemoprophylaxis and Oncopharmacology, I. N. Petrov Research Institute of Oncology, Ministry of Health of the Russian Federation

Email: iravasilyeva@hotmail.com
Россия, St. Petersburg

I. Vasil’eva

Research Laboratory of Cancer Chemoprophylaxis and Oncopharmacology, I. N. Petrov Research Institute of Oncology, Ministry of Health of the Russian Federation; International Research Centre “Biotechnologies of the Third Millennium”, ITMO University (St. Petersburg National Research University of Information Technologies, Mechanics and Optics

Автор, ответственный за переписку.
Email: iravasilyeva@hotmail.com
Россия, St. Petersburg; St. Petersburg

A. Semenov

Research Laboratory of Cancer Chemoprophylaxis and Oncopharmacology, I. N. Petrov Research Institute of Oncology, Ministry of Health of the Russian Federation; International Research Centre “Biotechnologies of the Third Millennium”, ITMO University (St. Petersburg National Research University of Information Technologies, Mechanics and Optics

Email: iravasilyeva@hotmail.com
Россия, St. Petersburg; St. Petersburg

M. Maidin

Research Laboratory of Cancer Chemoprophylaxis and Oncopharmacology, I. N. Petrov Research Institute of Oncology, Ministry of Health of the Russian Federation

Email: iravasilyeva@hotmail.com
Россия, St. Petersburg

N. Barakova

International Research Centre “Biotechnologies of the Third Millennium”, ITMO University (St. Petersburg National Research University of Information Technologies, Mechanics and Optics

Email: iravasilyeva@hotmail.com
Россия, St. Petersburg

A. Stukov

Research Laboratory of Cancer Chemoprophylaxis and Oncopharmacology, I. N. Petrov Research Institute of Oncology, Ministry of Health of the Russian Federation

Email: iravasilyeva@hotmail.com
Россия, St. Petersburg

Дополнительные файлы

Доп. файлы
Действие
1. JATS XML

© Springer Science+Business Media New York, 2017

Согласие на обработку персональных данных

 

Используя сайт https://journals.rcsi.science, я (далее – «Пользователь» или «Субъект персональных данных») даю согласие на обработку персональных данных на этом сайте (текст Согласия) и на обработку персональных данных с помощью сервиса «Яндекс.Метрика» (текст Согласия).